查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301040

生物芯片市場規模、份額和趨勢分析報告：按類型（DNA 芯片、芯片實驗室、細胞陣列、組織陣列、蛋白質芯片）、最終用途、地區、細分市場趨勢，2023-2030 年

Biochip Market Size, Share & Trends Analysis Report, By Type (DNA Chips, Lab-on-Chip, Cell Arrays, Tissue Arrays, Protein Chips), By End Use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

生物芯片市場增長和趨勢

根據 Grand View Research, Inc. 最新報告，到 2030 年，全球生物芯片市場規模將達到 259.2 億美元，預計將以年復合增長率為12.66%。

對藥物發現和藥物開發的需求不斷增長，加上個性化醫療的採用，可能會促進該行業的增長。 此外，世界各地的生物技術公司越來越多地採用下一代測序，這也推動了產品需求。 例如，2021 年 12 月，雅培的 i-STAT TBI 血漿測試獲得了 CE 標誌，這是一種便攜式創傷性腦損傷 (TBI) 血液分析儀。 因此，該公司被允許擴大在歐盟（EU）的業務。 測序技術的創新使研究人員能夠將 DNA 分子解碼到完整人類基因組的水平。

Thermo Fisher Scientific 的 Ion Torrent 芯片是基於合成測序技術的幾種技術之一。 該芯片是新一代測序 (NGS) 技術的進步，使大規模並行測序對於任何實驗室來說都具有成本效益。 因此，開發生物芯片以增強NGS應用預計將支持行業增長。 同樣，越來越多的政府舉措促進國內生物芯片生產可能會支持未來幾年的增長。 這一戰略舉措旨在滿足當地對我們產品的需求和供應。 例如，2022 年 7 月，SiPhox, Inc. 從 Baker Polito 政府獲得了價值 681,631 美元的贈款。

這筆資金將加速大規模生產可插拔光子生物芯片的製造設施的開發。 預計生物芯片的月產量將從約100個加速至約5,000個，以滿足藥物發現、疫苗開發和分佈式診斷等生物技術領域不斷增長的需求。 預計此類投資將在未來幾年補充行業增長。 預計 COVID-19 大流行將對預測期內的行業增長產生積極影響。 多家公司共同努力開發創新解決方案來應對這一流行病。 例如，2020 年 3 月，SkyWater Technology 宣布與華大智造合作，為 COVID-19 測序提供必要的組件，包括微流控 MEMS 設備。

對個性化醫療日益增長的需求很可能成為未來幾年該行業的關鍵應用領域。 隨著生物芯片已成為分子診斷的重要組成部分，它們在即時診斷中的使用預計將促進個性化藥物的開發。 此外，使用微陣列進行基因表達譜分析有望推進基於分子分類的個體化癌症治療。 然而，生產生物芯片的成本相當高，對最終用戶來說價格昂貴。 例如，Josep Carreras 白血病研究所 (IJC) 為研究人員提供微陣列。 GeneChip Human Gene 2.0 ST 全轉錄本表達分析和新鮮樣品的分析成本為 456 美元至 593 美元。

生物芯片市場報告亮點

  • 由於對快速、準確的癌症檢測的高需求，DNA 芯片類型細分市場在 2022 年佔據了最大的收入份額。
  • 由於生物芯片有助於降低藥物發現和開發的總體成本，芯片實驗室藥物發現應用領域預計將在預測期內快速增長。
  • 由於對個性化藥物的需求以及藥物發現和開發的增加，生物技術和製藥公司的最終用戶部門將在 2022 年獲得大量收入份額。
  • 由於高額研發投資以及通過風險投資和生物芯片應用開發為初創公司提供資金，北美在 2022 年佔據了最大的收入份額。
  • 預計 2023 年至 2030 年，亞太地區將以最快的複合年增長率增長。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 段定義
  • 信息獲取
  • 信息或數據分析
  • 市場範圍和細分定義
  • 市場模式
    • 按公司市場份額進行市場調查
    • 區域分析

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第三章市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 相關/補充市場前景
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
  • 行業分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19 的影響分析

第 4 章按類型劃分的業務分析

  • 生物芯片市場：類型變化分析
  • DNA芯片
    • DNA 芯片市場，2018-2030 年（百萬美元）
    • 癌症診斷和治療
    • 基因表達
    • SNP 基因分型
    • 基因組學
    • 藥物發現
    • 農業生物技術
    • 其他
  • 蛋白質芯片
    • 2018-2030 年蛋白質芯片市場（百萬美元）
    • 蛋白質組學
    • 表達分析
    • 診斷
    • 高溫超導
    • 藥物發現
    • 其他
  • 芯片實驗室
    • 芯片實驗室市場，2018-2030 年（百萬美元）
    • 基因組學
    • IVD 和 POC
    • 蛋白質組學
    • 藥物發現
    • 其他
  • 組織陣列
    • 2018-2030 年組織芯片市場（百萬美元）
  • 組織陣列
    • 2018-2030 年組織芯片市場（百萬美元）

第 5 章最終用途業務分析

  • 生物芯片市場：最終用途變化分析
  • 學術研究機構
    • 2018-2030 年學術研究市場（百萬美元）
  • 製藥和生物技術公司
    • 2018-2030 年製藥和生物技術企業市場（百萬美元）
  • 醫院和診斷中心
    • 2018-2030 年醫院和診斷中心市場（百萬美元）
  • 其他
    • 其他市場，2018-2030 年（百萬美元）

第 6 章區域業務分析

  • 2022 年和 2030 年按地區劃分的生物芯片市場份額
  • 北美
    • SWOT分析
    • 2018-2030 年北美生物芯片市場（百萬美元）
    • 美國
    • 加拿大
  • 歐洲
    • SWOT分析
    • 2018-2030 年歐洲生物芯片市場（百萬美元）
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 2018-2030 年亞太生物芯片市場（百萬美元）
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 泰國
    • 韓國
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲生物芯片市場，2018-2030 年（百萬美元）
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • SWOT分析
    • MEA 生物芯片市場，2018-2030 年（百萬美元）
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第7章競爭格局

  • 公司分類
  • 戰略規劃
  • 2022 年公司市場份額分析
  • 公司簡介/列表
    • Thermo Fisher Scientific, Inc
    • Agilent Technologies, Inc.
    • PerkinElmer Inc.
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • Standard BioTools
    • GE Healthcare
    • LI-COR, Inc.
    • QIAGEN
    • Randox Laboratories Ltd
Product Code: GVR-1-68038-077-4

Biochips Market Growth & Trends

The global biochips market size is expected to reach USD 25.92 billion by 2030, registering a CAGR of 12.66% during the forecast period, according to a new report by Grand View Research, Inc. The rising requirement for drug discovery and development coupled with the adoption of personalized medicine is likely to favor the industry's growth. Furthermore, the rise in the implementation of next-generation sequencing by biotechnology companies around the globe is pushing product demand. For instance, in December 2021, Abbott received CE Mark for the i-STAT TBI Plasma test, a portable analyzer for Traumatic Brain Injury (TBI) blood. Hence, the company is permitted to expand its footprint in the European Union. The innovation in sequencing techniques has allowed researchers to decode DNA molecules up to the level of the complete human genome.

Ion Torrent chip by Thermo Fisher Scientific is one of the technologies based on sequencing by the technique of synthesis. The chip is an advancement in the Next-Generation Sequencing (NGS) technology that makes massively parallel sequencing cost-effective for every lab. Hence, the development of biochips to enhance the NGS application is anticipated to support the growth of the industry. Similarly, increasing government-based initiatives to promote the domestic production of biochips is likely to support the growth in the coming years. This strategic initiative is to match the local demand for the product with the supply. For instance, in July 2022, SiPhox, Inc. received a grant worth USD 681,631 from the Baker-Polito Administration.

The financial support is to accelerate the development of a manufacturing facility for the mass production of pluggable photonic biochips. It is estimated to accelerate the output to around 5,000 biochips per month from around 100 per month to match the rising demand from biotech segments including drug discovery, vaccine development, and distributed diagnostics. Such investments are likely to supplement the industry growth in the coming years. The COVID-19 pandemic is estimated to have a positive impact on industry growth during the forecasted period. Various companies collaborated to develop innovative solutions to deal with the pandemic. For instance, in March 2020, SkyWater Technology announced the collaboration with MGI, to supply essential components for COVID-19 sequencing, including microfluidic MEMS devices.

The growing requirement for personalized medicine is likely to become a key application area for the industry in the coming years. Since biochip is emerging as an important component in molecular diagnostics, their use in point-of-care diagnostics is anticipated to smooth the development of personalized medicines. In addition, gene expression profiling through microarrays is expected to enhance the progress of personalized treatment for cancer based on molecular classification. However, the cost involved in the manufacturing of biochips is considerably high, resulting in high pricing for end-users. For instance, Josep Carreras Leukaemia Research Institute (IJC) provides microarray to researchers. The cost of GeneChip Human Gene 2.0 ST for whole-transcript expression analysis & profiling ranges from USD 456 to 593 for fresh samples.

Biochips Market Report Highlights

  • The DNA chips type segment accounted for the largest revenue share in 2022 due to the high demand for rapid and accurate detection of cancer
  • The drug discovery application segment for lab-on-chip is anticipated to grow at a faster rate during the forecast period as the biochip helps lower the overall cost of drug discovery & development
  • The biotechnology and pharmaceutical companies end-user segment captured a significant revenue share in 2022 due to the need for personalized medicines along with the increasing drug discovery & development
  • North America held the largest revenue share in 2022 owing to high R&D investment coupled with the accessibility of capital through venture capitalists for startups and the application development of biochips in the region
  • Asia Pacific is projected to register the fastest CAGR from 2023 to 2030 owing to various initiatives by local governments to promote domestic product manufacturing

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
  • 1.2. Information Procurement
  • 1.3. Information Or Data Analysis
  • 1.4. Market Scope & Segment Definition
  • 1.5. Market Model
    • 1.5.1. Market Study, By Company Market Share
    • 1.5.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in adoption of next-generation sequencing
      • 3.2.1.2. Growing R&D in proteomics and genomics
      • 3.2.1.3. Presence of an extensive drug-development pipeline
      • 3.2.1.4. Increasing adoption of personalized medicine
      • 3.2.1.5. Rapid technological advances in biochip technology
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of manufacturing
      • 3.2.2.2. Lack of knowledge regarding biochips
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Biochip Market: Type Movement Analysis
  • 4.2. DNA Chips
    • 4.2.1. DNA Chips Market, 2018 - 2030 (USD Million)
    • 4.2.2. Cancer Diagnosis and Treatment
      • 4.2.2.1. Cancer Diagnosis and Treatment Market, 2018 - 2030 (USD Million)
    • 4.2.3. Gene Expression
      • 4.2.3.1. Gene Expression Market, 2018 - 2030 (USD Million)
    • 4.2.4. SNP Genotyping
      • 4.2.4.1. SNP Genotyping Market, 2018 - 2030 (USD Million)
    • 4.2.5. Genomics
      • 4.2.5.1. Genomics Market, 2018 - 2030 (USD Million)
    • 4.2.6. Drug Discovery
      • 4.2.6.1. Drug Discovery Market, 2018 - 2030 (USD Million)
    • 4.2.7. Agricultural Biotechnology
      • 4.2.7.1. Agricultural Biotechnology Market, 2018 - 2030 (USD Million)
    • 4.2.8. Others
      • 4.2.8.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. Protein Chips
    • 4.3.1. Protein Chips Market, 2018 - 2030 (USD Million)
    • 4.3.2. Proteomics
      • 4.3.2.1. Proteomics Market, 2018 - 2030 (USD Million)
    • 4.3.3. Expression Profiling
      • 4.3.3.1. Expression Profiling Market, 2018 - 2030 (USD Million)
    • 4.3.4. Diagnostics
      • 4.3.4.1. Diagnostics Market, 2018 - 2030 (USD Million)
    • 4.3.5. HTS
      • 4.3.5.1. HTS Market, 2018 - 2030 (USD Million)
    • 4.3.6. Drug Discovery
      • 4.3.6.1. Drug Discovery Market, 2018 - 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others Market, 2018 - 2030 (USD Million)
  • 4.4. Lab-on- chips
    • 4.4.1. Lab-on- Chips Market, 2018 - 2030 (USD Million)
    • 4.4.2. Genomics
      • 4.4.2.1. Genomics Market, 2018 - 2030 (USD Million)
    • 4.4.3. IVD & POC
      • 4.4.3.1. IVD & POC Market, 2018 - 2030 (USD Million)
    • 4.4.4. Proteomics
      • 4.4.4.1. Proteomics Market, 2018 - 2030 (USD Million)
    • 4.4.5. Drug Discovery
      • 4.4.5.1. Drug DiscoveryMarket, 2018 - 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Tissue Arrays
    • 4.5.1. Tissue Arrays Market, 2018 - 2030 (USD Million)
  • 4.6. Cell Arrays
    • 4.6.1. Cell Arrays Market, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

  • 5.1. Biochip Market: End-Use Movement Analysis
  • 5.2. Academic and Research Institutes
    • 5.2.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)
  • 5.3. Pharmaceutical & Biotechnology Companies
    • 5.3.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 5.4. Hospitals and Diagnostics Centers
    • 5.4.1. Hospitals and Diagnostics Centers Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Biochip Market Share By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. SWOT Analysis
    • 6.2.2. North America Biochip Market, 2018 - 2030 (USD Million)
    • 6.2.3. U.S.
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Target Disease Prevalence
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. U.S. Biochip Market, 2018 - 2030 (USD Million)
    • 6.2.4. Canada
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Target Disease Prevalence
      • 6.2.4.3. Competitive Scenario
      • 6.2.4.4. Canada Biochip Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. SWOT Analysis
    • 6.3.2. Europe Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Target Disease Prevalence
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. UK Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.4. Germany
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Target Disease Prevalence
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. Germany Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.5. France
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Target Disease Prevalence
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. France Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.6. Italy
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Target Disease Prevalence
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Italy Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.7. Spain
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Target Disease Prevalence
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Spain Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.8. Denmark
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Target Disease Prevalence
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Denmark Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.9. Sweden
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Target Disease Prevalence
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Sweden Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.10. Norway
      • 6.3.10.1. Key Country Dynamics
      • 6.3.10.2. Target Disease Prevalence
      • 6.3.10.3. Competitive Scenario
      • 6.3.10.4. Norway Biochip Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. SWOT Analysis
    • 6.4.2. Asia Pacific Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Japan Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.4. China
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. China Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.5. India
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Target Disease Prevalence
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. India Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Target Disease Prevalence
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Australia Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Target Disease Prevalence
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Thailand Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.8. South Korea
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Target Disease Prevalence
      • 6.4.8.3. Competitive Scenario
      • 6.4.8.4. South Korea Biochip Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. SWOT Analysis
    • 6.5.2. Latin America Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.3. Brazil
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Brazil Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Mexico Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.5. Argentina
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Argentina Biochip Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. SWOT Analysis
    • 6.6.2. MEA Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.3. South Africa
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. South Africa Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.4. Saudi Arabia
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Saudi Arabia Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.5. UAE
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. UAE Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.6. Kuwait
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Kuwait Biochip Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Thermo Fisher Scientific, Inc
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Agilent Technologies, Inc.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. PerkinElmer Inc.
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Illumina, Inc.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Bio-Rad Laboratories, Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Standard BioTools
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. GE Healthcare
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. LI-COR, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. QIAGEN
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Randox Laboratories Ltd
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 5 Global Biochip Market, By End-Use, 2018 - 2030 (USD Million
  • TABLE 6 Global Biochip Market, By Region, 2018 - 2030 (USD Million)
  • TABLE 7 North America Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 8 North America Biochip Market, By Type, 2018 - 2030 (USD Million),
  • TABLE 9 North America Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 10 U.S. Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 11 U.S. Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 12 Canada Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 13 Canada Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 14 Europe Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 15 Europe Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 16 Europe Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 17 UK Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 18 UK Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 19 Germany Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 20 Germany Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 21 France Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 22 France Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 23 Spain Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 24 Spain Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 25 Italy Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 26 Italy Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 27 Denmark Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 28 Denmark Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 29 Norway Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 30 Norway Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 31 Sweden Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 32 Sweden Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 33 Asia Pacific Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 34 Asia Pacific Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 35 Asia Pacific Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 36 China Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 37 China Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 38 Japan Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 39 Japan Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 40 India Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 41 India Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 42 South Korea Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 43 South Korea Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 44 Australia Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 45 Australia Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 46 Thailand Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 47 Thailand Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 48 Latin America Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 49 Latin America Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 50 Latin America Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 51 Brazil Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 52 Brazil Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 53 Mexico Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 54 Mexico Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 55 Argentina Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 56 Argentina Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 57 MEA Biochip Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 58 MEA Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 59 MEA Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 60 South Africa Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 61 South Africa Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 62 UAE Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 63 UAE Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 64 Saudi Arabia Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 65 Saudi Arabia Biochip Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 66 Kuwait Biochip Market, By Type, 2018 - 2030 (USD Million)
  • TABLE 67 Kuwait Biochip Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 biochip market segmentation.
  • FIG. 8 Market snapshot, 2022
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 PESTEL analysis
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Global biochip market: Type movement analysis
  • FIG. 15 Global biochip market, for DNA chips, 2018 - 2030 (USD Million)
  • FIG. 16 Global biochip market, for cancer diagnosis and treatment, 2018 - 2030 (USD Million)
  • FIG. 17 Global biochip market, for gene expression, 2018 - 2030 (USD Million)
  • FIG. 18 Global biochip market, for SNP genotyping, 2018 - 2030 (USD Million)
  • FIG. 19 Global biochip market, for genomics, 2018 - 2030 (USD Million)
  • FIG. 20 Global biochip market, for drug discovery, 2018 - 2030 (USD Million)
  • FIG. 21 Global biochip market, for agricultural biotechnology, 2018 - 2030 (USD Million)
  • FIG. 22 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 23 Global biochip market, for protein chips, 2018 - 2030 (USD Million)
  • FIG. 24 Global biochip market, for proteomics, 2018 - 2030 (USD Million)
  • FIG. 25 Global biochip market, for expression profiling, 2018 - 2030 (USD Million)
  • FIG. 26 Global biochip market, for diagnostics, 2018 - 2030 (USD Million)
  • FIG. 27 Global biochip market, for HTS, 2018 - 2030 (USD Million)
  • FIG. 28 Global biochip market, for drug discovery, 2018 - 2030 (USD Million)
  • FIG. 29 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 30 Global biochip market, for lab-on-chip, 2018 - 2030 (USD Million)
  • FIG. 31 Global biochip market, for genomics, 2018 - 2030 (USD Million)
  • FIG. 32 Global biochip market, for IVD& POC, 2018 - 2030 (USD Million)
  • FIG. 33 Global biochip market, for proteomics, 2018 - 2030 (USD Million)
  • FIG. 34 Global biochip market, for drug discovery, 2018 - 2030 (USD Million)
  • FIG. 35 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 36 Global biochip market, for tissue arrays, 2018 - 2030 (USD Million)
  • FIG. 37 Global biochip market, for cell arrays, 2018 - 2030 (USD Million)
  • FIG. 38 Global biochip market: End-Use movement analysis
  • FIG. 39 Global biochip market, for academic and research institutes, 2018 - 2030 (USD Million)
  • FIG. 40 Global biochip market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • FIG. 41 Global biochip market, for hospitals and diagnostics centers, 2018 - 2030 (USD Million)
  • FIG. 42 Global biochip market, for others, 2018 - 2030 (USD Million)
  • FIG. 43 Regional marketplace: Key takeaways
  • FIG. 44 Regional outlook, 2022 & 2030
  • FIG. 45 Global biochip market: Region movement analysis
  • FIG. 46 North America biochip market, 2018 - 2030 (USD Million)
  • FIG. 47 U.S. biochip market, 2018 - 2030 (USD Million)
  • FIG. 48 Canada biochip market, 2018 - 2030 (USD Million)
  • FIG. 49 Europe biochip market, 2018 - 2030 (USD Million)
  • FIG. 50 Germany biochip market, 2018 - 2030 (USD Million)
  • FIG. 51 UK biochip market, 2018 - 2030 (USD Million)
  • FIG. 52 France biochip market, 2018 - 2030 (USD Million)
  • FIG. 53 Italy biochip market, 2018 - 2030 (USD Million)
  • FIG. 54 Spain biochip market, 2018 - 2030 (USD Million)
  • FIG. 55 Denmark biochip market, 2018 - 2030 (USD Million)
  • FIG. 56 Sweden biochip market, 2018 - 2030 (USD Million)
  • FIG. 57 Norway biochip market, 2018 - 2030 (USD Million)
  • FIG. 58 Asia Pacific biochip market, 2018 - 2030 (USD Million)
  • FIG. 59 Japan biochip market, 2018 - 2030 (USD Million)
  • FIG. 60 China biochip market, 2018 - 2030 (USD Million)
  • FIG. 61 India biochip market, 2018 - 2030 (USD Million)
  • FIG. 62 Australia biochip market, 2018 - 2030 (USD Million)
  • FIG. 63 South Korea biochip market, 2018 - 2030 (USD Million)
  • FIG. 64 Thailand biochip market, 2018 - 2030 (USD Million)
  • FIG. 65 Latin America biochip market, 2018 - 2030 (USD Million)
  • FIG. 66 Brazil biochip market, 2018 - 2030 (USD Million)
  • FIG. 67 Mexico biochip market, 2018 - 2030 (USD Million)
  • FIG. 68 Argentina biochip market, 2018 - 2030 (USD Million)
  • FIG. 69 Middle East and Africa biochip market, 2018 - 2030 (USD Million)
  • FIG. 70 South Africa biochip market, 2018 - 2030 (USD Million)
  • FIG. 71 Saudi Arabia biochip market, 2018 - 2030 (USD Million)
  • FIG. 72 UAE biochip market, 2018 - 2030 (USD Million)
  • FIG. 73 Kuwait biochip market, 2018 - 2030 (USD Million)